MEA Wearable Cardioverter Defibrillator Market

MEA Wearable Cardioverter Defibrillator Market Size (2023 to 2028)

The Wearable Cardioverter Defibrillator Market size in the Middle East and Africa is predicted to grow at a slow rate from 2023 to 2028.

The wearable cardioverter defibrillator market in the MEA region is majorly driven by an increase in the incidence of cardiac arrest, growing awareness towards public access defibrillators, and a growing geriatric population across the region. Also, technological advancements such as the advent of automated external defibrillators for public access places and improving healthcare infrastructure.

In addition, growing concern for death caused due to cardiomyopathy, endocarditis, and myocarditis are projected to increase during the forecast period. Therefore, the rising number of individuals with cardiac illnesses and advances in cardiology are likely to be the primary growth drivers for the wearable cardioverter-defibrillator in the region. Furthermore, government initiatives to create awareness among the people and conduct medical tourism in emerging countries such as South Africa, UAE, and Saudi Arabia enable market growth. 

A patient with a recent myocardial infarction and left ventricular failure, for example, can utilize the device in an event when there is no clear need for installing implantable devices. Wearable cardioverter-defibrillator devices are becoming more common as they may be used. At the same time, a patient waits for an implanted one owing to surgical restrictions, and they reduce the chance of cardiac arrest. Moreover, the rapid advancements in automated external defibrillators and increasing healthcare spending are majorly driving the market growth. Increasing investment and funding by private and government organizations, changes in disease prevalence rate, and rising service cost are the other factors that uplift market growth. 

Cardiovascular disease is the leading cause of mortality. As a result, many new firms are interested in investing in new technologies that will enable them to provide enhanced diagnostic and treatment alternatives. The regional market players are adopting advanced technology through which market expansion is made possible. 

However, the cardioverter-defibrillator is still relatively unknown in developing nations, which might be a stumbling block to market growth. Furthermore, the use of wearable cardioverter-defibrillators has been hampered even further by the lack of agreed standards. Again, in several low-income countries, there are no stringent criteria or regulations in place to assess the safety and quality of wearable cardioverter-defibrillators.

This research report on the Middle East and Africa Wearable Cardioverter Defibrillator Market has been segmented and sub-segmented into the following categories:

By Conditions:

• Peripartum Cardiomyopathy
• Congenital Heart Disease
• Inherited Arrhythmias

By End User:

• Hospitals
• Home Care Settings
• Cardiology Clinics

By Country:

• KSA
• UAE
• Israel
• Rest Of GCC Countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• Rest Of MEA

Geographically, the Middle East and African market are expected to record a moderate share in the global Wearable Cardioverter Defibrillator Market during the forecast period. The market in the region is attributed to the rising prevalence of cardiovascular disorders, improving the healthcare sector, and offering rental services for wearable cardioverter-defibrillators. Also, lowering the cost and making it accessible in emerging nations, technological advancements assist in introducing patient-friendly equipment that enhances market growth. Other reasons driving the wearable cardioverter defibrillator market in emerging nations like South Africa, Saudi Arabia, and the United Arab Emirates are rising per capita income, increased awareness of cardiac disorders, and cardiac arrests. The prevalence of sudden cardiac arrest is directly proportional to the increasing population; rapid growth in the geriatric population and a rise in the number of sudden cardiac arrest cases drive the MEA wearable cardioverter defibrillators market.

In MEA regional market, South Africa and Saudi Arabia accounted for the highest share in the market owing to the improving healthcare sector, increasing investments by the government and private organizations for infrastructure development. In addition, technological developments in wearable cardioverter-defibrillator devices include reduced electrode noise, improved signal detection, and device weight and size reduction to make it more comfortable for the patient.

KEY MARKET PLAYERS:

A few of the key companies operating in the MEA Wearable Middle East and Africa Cardioverter Defibrillator Market analyzed in this report are LivaNova PLC (U.K.), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), Cardiac Science Corporation (U.S.), Physio-Control, Inc. (U.S.), Medtronic PLC (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), and Nihon Kohden Corporation (Japan).